{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:50:33Z","timestamp":1791319833447,"version":"4.3.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jneuroim.2026.579004","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:29:54Z","timestamp":1781566194000},"page":"579004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anti-adenylate kinase 5 encephalitis: Case series and review of 18F-DPA714 PET\/MRI radiographic changes"],"prefix":"10.1016","volume":"419","author":[{"given":"Siyu","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2026.579004_bb0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-immunol-083122-044829","article-title":"B cell-directed therapy in autoimmunity","volume":"42","author":"Abeles","year":"2024","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0010","doi-asserted-by":"crossref","first-page":"12626","DOI":"10.1038\/s41598-021-92147-6","article-title":"Identification of novel DNA hypermethylation of the adenylate kinase 5 promoter in colorectal adenocarcinoma","volume":"11","author":"Ahn","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0015","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.molimm.2003.10.005","article-title":"Innate immunity: an overview","volume":"40","author":"Beutler","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.576975","article-title":"Identification of adenylate kinase 5 antibodies during routine diagnostics in a tissue-based assay: three new cases and a review of the literature","volume":"334","author":"Bien","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/cmi.2009.3","article-title":"Cell death mechanisms induced by cytotoxic lymphocytes","volume":"6","author":"Ch\u00e1vez-Gal\u00e1n","year":"2009","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1212\/WNL.0000000000000570","article-title":"Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease","volume":"83","author":"Dale","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2026.579004_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1004795","article-title":"Anti-CD20 therapies in multiple sclerosis: from pathology to the clinic","volume":"14","author":"de S\u00e8ze","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0040","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1212\/WNL.0000000000003586","article-title":"Characteristics in limbic encephalitis with anti-adenylate kinase 5 autoantibodies","volume":"88","author":"Do","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2026.579004_bb0045","doi-asserted-by":"crossref","first-page":"10156","DOI":"10.1073\/pnas.152259999","article-title":"Energetic communication between mitochondria and nucleus directed by catalyzed phosphotransfer","volume":"99","author":"Dzeja","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jneuroim.2026.579004_bb0050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","article-title":"Antibodies and neuronal autoimmune disorders of the CNS","volume":"257","author":"Graus","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0055","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s13760-021-01853-5","article-title":"Anti-AK5 encephalitis: subacute anterograde amnesia is not the only clinical presentation","volume":"123","author":"Guillaume","year":"2023","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0060","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/aww017","article-title":"Early and protective microglial activation in Alzheimer\u2019s disease: a prospective study using 18F-DPA-714 PET imaging","volume":"139","author":"Hamelin","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2026.579004_bb0065","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/eji.201242480","article-title":"Role of inflammatory dendritic cells in innate and adaptive immunity","volume":"42","author":"Hespel","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jns.2016.04.037","article-title":"Down-regulation of adenylate kinase 5 in temporal lobe epilepsy patients and rat model","volume":"366","author":"Lai","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.12779\/dnd.2022.21.2.71","article-title":"Translocator protein (18 kDa) polymorphism (rs6971) in the Korean population","volume":"21","author":"Lee","year":"2022","journal-title":"Dement Neurocogn Disord."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2023.100218","article-title":"Anti-adenylate kinase 5 encephalitis: clinical characteristics, diagnosis, and management of this rare entity","volume":"7","author":"Li","year":"2023","journal-title":"J Transl Autoimmun."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577861","article-title":"Adenylate kinase 5 (AK5) autoimmune encephalitis: clinical presentations and outcomes in three new patients","volume":"367","author":"McKeon-Makki","year":"2022","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0095","doi-asserted-by":"crossref","first-page":"7592","DOI":"10.1007\/s00415-024-12690-w","article-title":"(18)F-DPA714 PET\/MRI as a potential imaging tool for detecting possible antibody-negative autoimmune encephalitis: a prospective study","volume":"271","author":"Meng","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0100","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1007\/s00259-025-07305-z","article-title":"Comparison of (18)F-DPA714 PET\/MRI and (18)F-FDG PET\/CT in patients with autoimmune encephalitis: a cross-sectional study","volume":"52","author":"Meng","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jneuroim.2026.579004_bb0105","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/brain\/awab153","article-title":"Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis","volume":"144","author":"Mu\u00f1iz-Castrillo","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2026.579004_bb0110","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nri.2016.153","article-title":"Programmed cell death and the immune system","volume":"17","author":"Nagata","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jneuroim.2015.08.009","article-title":"Clinico-pathological correlation in adenylate kinase 5 autoimmune limbic encephalitis","volume":"287","author":"Ng","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0120","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1073\/pnas.0407459102","article-title":"The crystal structure of human adenylate kinase 6: an adenylate kinase localized to the cell nucleus","volume":"102","author":"Ren","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jneuroim.2026.579004_bb0125","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.febslet.2009.07.047","article-title":"Identification of two active functional domains of human adenylate kinase 5","volume":"583","author":"Solaroli","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0130","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001088","article-title":"Rituximab treatment and long-term outcome of patients with autoimmune encephalitis: real-world evidence from the GENERATE registry","volume":"8","author":"Thaler","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0135","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jneuroim.2007.03.015","article-title":"Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis","volume":"186","author":"T\u00fcz\u00fcn","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0140","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2026.579004_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00760","article-title":"B and T cells driving multiple sclerosis: identity, mechanisms and potential triggers","volume":"11","author":"van Langelaar","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0150","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1432-1327.1999.00294.x","article-title":"Identification of a novel human adenylate kinase. cDNA cloning, expression analysis, chromosome localization and characterization of the recombinant protein","volume":"261","author":"Van Rompay","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0155","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001010","article-title":"Anti-adenylate kinase 5 encephalitis with histologic evidence of CNS vasculitis","volume":"8","author":"Vicino","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0160","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70107","article-title":"Microglial activation visualized by [(18)F]-DPA714 PET is a potential marker of severity and prognosis for anti-LGI1 encephalitis","volume":"32","author":"Wang","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579004_bb0165","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.230397","article-title":"Microglial activation imaging using (18)F-DPA-714 PET\/MRI for detecting autoimmune encephalitis","volume":"310","author":"Zhang","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.jneuroim.2026.579004_bb0170","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00234-019-02212-1","article-title":"Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma","volume":"61","author":"Zoccarato","year":"2019","journal-title":"Neuroradiology"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:56:59Z","timestamp":1791316619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826001530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"alternative-id":["S0165572826001530"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579004","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-adenylate kinase 5 encephalitis: Case series and review of 18F-DPA714 PET\/MRI radiographic changes","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"579004"}}